Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
J Surg Case Rep ; 2021(8): rjab305, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34394911

ABSTRACT

We report our experience with needlescopic splenectomy (NS) for the surgical treatment of idiopathic thrombocytopenic purpura using a 3-mm needlescope with three ports. One patient was male and two were females, and their mean age was 58 years. The patient was placed in the right lateral decubitus position. The first 12-mm port was introduced through the lateral margin of the left rectus abdominis muscle, and the other two 3-mm ports were inserted in the left upper quadrant. NS was performed by a standard technique under the observation of 3.3-mm needlescope. The surgical procedure was successfully completed in all the patients. The mean duration of surgery, intra-operative bleeding volume and post-operative hospital stay were 176 min, 70 ml and 4.7 days, respectively. There were no particular peri-operative complications in spite of dense adhesions or simultaneous laparoscopic procedures. Our method is safe and feasible with low morbidity and without impairing cosmetic benefits.

2.
Oncotarget ; 11(34): 3198-3207, 2020 Aug 25.
Article in English | MEDLINE | ID: mdl-32922660

ABSTRACT

Liquid biopsy is a non-invasive tool to examine the genetic profile of tumors by identification of mutated circulating tumor DNA (ctDNA), which is often analyzed by next generation sequencing (NGS) or droplet digital PCR (ddPCR) assay. We first examined the ctDNA mutation in pre-operative plasma samples obtained from 154 colorectal cancer (CRC) and 46 gastric cancer (GC) patients, using the NGS-based panel assay. The overall detection rate of mutated ctDNA was 72.0% (144 of 200 patients), and the panel-based screening identified 207 and 47 mutations from CRC and GC patients, respectively. The ddPCR analysis was then performed on post-operative samples of 77 patients, and detection of mutated ctDNA was earlier than imaging-based diagnosis in all of 6 patients who showed the tumor recurrences after surgery. Our data also revealed that patients with positive post-operation ctDNA level showed significant shorter recurrence-free survival compared to the patients with negative ctDNA level (HR 14.9; 95% CI, 0.7-313.5; p < 0.0001). These findings suggested that screening of mutated ctDNA by liquid biopsy aids in identifying the patients at high risk of post-operative recurrence, and serial screening of ctDNA would allow to monitor the response after treatment and/or early detection of tumor recurrence.

3.
Clin Exp Gastroenterol ; 7: 47-52, 2014.
Article in English | MEDLINE | ID: mdl-24648748

ABSTRACT

PURPOSE: Serotonin (5-hydroxytryptamine [5-HT])3 receptor antagonists are effective for the treatment of diarrhea-predominant irritable bowel syndrome (IBS-D), in which exaggerated intestinal/colonic hypermotility is often observed. Recent studies have suggested that the motility disorder, especially spastic hypermotility, seen in the neorectum following sphincter-preserving operations for rectal cancer may be the basis of the postoperative defecatory malfunction seen in these patients. We investigated the efficacy of 5-HT3 receptor antagonists in patients suffering from severe low anterior resection syndrome. PATIENTS AND METHODS: A total of 25 male patients with complaints of uncontrollable urgency or fecal incontinence following sphincter-preserving operations were enrolled in this study. Defecatory status, assessed on the basis of incontinence score (0-20), urgency grade (0-3), and number of toilet visits per day, was evaluated using a questionnaire before and 1 month after the administration of the 5-HT3 antagonist ramosetron. RESULTS: All the parameters assessed improved significantly after taking ramosetron for 1 month. The effect was more prominent in cases whose anastomotic line was lower, ie, inside the anal canal. Defecatory function was better in patients who commenced ramosetron therapy within 6 months postoperatively, as compared to those who were not prescribed ramosetron for more than 7 months postoperatively. CONCLUSION: These results suggest that 5-HT3 antagonists are effective for the treatment of low anterior resection syndrome, as in diarrhea-predominant irritable bowel syndrome. The improvement in symptoms is not merely time dependent, but it is related to treatment with 5-HT3 antagonists.

4.
Oncol Rep ; 30(6): 2647-52, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24085263

ABSTRACT

Several essential oils possess pharmacological effects. Among the various constituents of essential oils, 1, 8-cineole has been shown to possess pharmacological effects such as anti-bacterial and anti-inflammatory effects. The effect of 1, 8-cineole on human colorectal cancer cells, however, has not reported previously. In this study, we have investigated the anti-proliferative effect of 1, 8-cineole on human colon cancer cell lines HCT116 and RKO by WST-8 and BrdU assays. The cytotoxicity of 1, 8-cineole was investigated by LDH activity and TUNEL staining. The mechanism of apoptosis by 1, 8-cineole was determined by western blot analyses. In in vivo study, RKO cells were injected into the SCID mice and the effect of 1, 8-cineole was investigated. Specific induction of apoptosis, not necrosis, was observed in human colon cancer cell lines HCT116 and RKO by 1, 8-cineole. The treatment with 1, 8-cineole was associated with inactivation of survivin and Akt and activation of p38. These molecules induced cleaved PARP and caspase-3, finally causing apoptosis. In xenotransplanted SCID mice, the 1, 8-cineole group showed significantly inhibited tumor progression compared to the control group. These results indicated 1, 8-cineole suppressed human colorectal cancer proliferation by inducing apoptosis. Based on these studies 1, 8-cineole would be an effective strategy to treat colorectal cancer.


Subject(s)
Apoptosis/drug effects , Carcinogenesis , Colonic Neoplasms/drug therapy , Cyclohexanols/administration & dosage , Monoterpenes/administration & dosage , Animals , Cell Proliferation/drug effects , Colonic Neoplasms/pathology , Cyclohexanols/adverse effects , Eucalyptol , HCT116 Cells , Humans , Mice , Monoterpenes/adverse effects , Xenograft Model Antitumor Assays
5.
Int J Oncol ; 43(2): 431-8, 2013 Aug.
Article in English | MEDLINE | ID: mdl-23754252

ABSTRACT

Fatty acid synthase is highly expressed in many types of human cancers. Cerulenin, a natural inhibitor of fatty acid synthase, induced apoptosis in the human colon cancer cell lines HCT116 and RKO. Oxaliplatin also induced cell death in these cell lines. Cerulenin treatment was associated with reduced levels of phosphorylated Akt, activation of p38 and induced caspase-3 cleavage and finally caused apoptosis. Oxaliplatin induced activation of the p53-p21 pathway and p38. In combination with cerulenin and oxaliplatin, activation of the p53-p21 pathway and p38 occurred in a smaller concentration and finally induced caspase-3 cleavage in a smaller concentration of cerulenin and oxaliplatin. In xenotransplanted SCID mice, the cerulenin + oxaliplatin group significantly inhibited tumor progression compared to the control, cerulenin and oxaliplatin groups. Based on these studies, inhibiting fatty acid synthase would be an effective strategy to treat unresectable colorectal cancer tumors in combination with oxaliplatin. Fatty acid synthase inhibitor would be one of the best counterparts of oxaliplatin, which reduces the dose and side-effects of oxaliplatin and would make it possible to endure the chemotherapy over a longer period.


Subject(s)
Antineoplastic Agents/therapeutic use , Cerulenin/therapeutic use , Colonic Neoplasms/drug therapy , Fatty Acid Synthesis Inhibitors/therapeutic use , Organoplatinum Compounds/therapeutic use , Animals , Antineoplastic Agents/pharmacology , Apoptosis/drug effects , Cell Line, Tumor , Cell Proliferation , Cell Survival , Cerulenin/pharmacology , Fatty Acid Synthases/antagonists & inhibitors , Fatty Acid Synthesis Inhibitors/pharmacology , HCT116 Cells , Humans , Mice , Neoplasm Transplantation , Organoplatinum Compounds/pharmacology , Oxaliplatin
6.
Okajimas Folia Anat Jpn ; 80(4): 77-84, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14964467

ABSTRACT

Aberrant biceps brachii muscles (BB); the right aberrant head, the left aberrant head, and the left aberrant bundle, were observed bilaterally in a 94-year-old Japanese female cadaver during a regional anatomy of the upper extremities. We examined the nerve supply as well as scrutinizing these aberrant BB. The branches to the right aberrant head and the right brachialis muscle arose as a common nerve trunk from the musculocutaneous nerve, and both branches entered each muscle from the ventral aspect. The branches to the superior portion of the left aberrant bundle and the short head of the BB arose as a common nerve trunk from the musculocutaneous nerve, and both branches entered each muscle from the dorsal aspect. The branches to the inferior portion of the left aberrant bundle and the left aberrant head arose separately from the musculocutaneous nerve, but they were found to be closely related after peeling off the epineurium. From these observations, we speculated that the right aberrant head could have differentiated from the brachialis muscle, the left aberrant head from the long head of the BB, and the left aberrant bundle aberrant head from the short and long head of the BB, based on the formation of the common nerve trunk and the close relation of the nerve fibers. Our suggested muscular differentiation agreed with the entering aspect (ventral/dorsal aspect) of the innervating nerve.


Subject(s)
Arm/anatomy & histology , Arm/innervation , Muscle, Skeletal/abnormalities , Muscle, Skeletal/innervation , Aged , Aged, 80 and over , Cadaver , Female , Humans , Muscle, Skeletal/anatomy & histology , Peripheral Nerves/anatomy & histology
SELECTION OF CITATIONS
SEARCH DETAIL
...